2-(2,4-Difluorophenyl)-1-(2-methylbenzimidazol-1-yl)-3-(1,2,4-triazol-1-yl)propan-2-ol

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并咪唑类
• 英文名称: 2-(2,4-Difluorophenyl)-1-(2-methylbenzimidazol-1-yl)-3-(1,2,4-triazol-1-yl)propan-2-ol
• 化学式: C₁₉H₁₇F₂N₅O
• 分子量: 369.4
• InChiKey: HLLCTGMHRJMCND-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  27
• 可旋转键数：
  5
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.21
• 拓扑面积：
  68.8
• 氢给体数：
  1
• 氢受体数：
  6

文献信息

• Novel anti-fungal agents
  申请人：Chandavarkar A Mohan

  公开号：US20050020653A1

  公开（公告）日：2005-01-27

  The invention relates to novel antifungal compounds and its pharmaceutically acceptable salts, having as part of its structure, imidazolyl or benzimidazolyl derivatives. The imidazolyl derivative may be substituted at 2 position from among the group consisting of aroyl, p-chloroaroyl, phenyl hydroxy methine or p-chloro phenyl hydroxy methine or with n-butyl at 2 position and chlorine at 4 and 5 position. In the alternative, when it is a benzimadazolyl derivative, with hydrogen at 6 position, the substituent at 2 position may be selected from among methyl, ethyl, isopropyl, 2-oxopropl-1-yl, n-propyl, methoxy methyl, propen-1-yl, phenyl, p-chlorophenyl, p-toluyl, benzyl, 4-pyridyl, p-methoxy phenyl, 3-pyridyl, o-methoxy phenyl, styryl, 2-cyano methyl, p-hydroxy phenyl, p-amino phenyl, p-toluyl sulfonyl methyl or p-(t-butyl) phenyl group and if hydrogen is at 2 position, the substituent at the 6 position is selected from among nitro, trifluoromethyl or methoxy group.

  本发明涉及新型抗真菌化合物及其药学上可接受的盐类，其结构中含有咪唑或苯并咪唑衍生物。咪唑衍生物可在 2 位被由芳基、对氯芳基、苯基羟基甲烷或对氯苯基羟基甲烷组成的组取代，或在 2 位被正丁基取代，在 4 位和 5 位被氯取代。另外，如果是苯并咪唑基衍生物，6 位上有氢，2 位上的取代基可以选自甲基、乙基、异丙基、2-氧代丙-1-基、正丙基、甲氧基甲基、丙烯-1-基、苯基、对氯苯基、对甲苯基、苄基、4-吡啶基、对甲氧基苯基、对氯苯基、4-吡啶基、3-吡啶基、4-吡啶基、5-吡啶基、6-吡啶基、7-吡啶基、8-吡啶基、9-吡啶基、对甲氧基苯基、3-吡啶基、邻甲氧基苯基、苯乙烯基、2-氰基甲基、对羟基苯基、对氨基苯基、对甲苯磺酰基甲基或对叔丁基苯基；如果氢位于 2 位，则位于 6 位的取代基可从硝基、三氟甲基或甲氧基中选择。
• US7226939B2
  申请人：——

  公开号：US7226939B2

  公开（公告）日：2007-06-05
• [EN] NOVEL ANTI-FUNGAL AGENTS<br/>[FR] NOUVELS AGENTS ANTI-FONGIQUES
  申请人：FDC LTD

  公开号：WO2003068142A2

  公开（公告）日：2003-08-21

  The invention relates to novel antifungal compounds and its pharmaceutically acceptable salts., having as part of its structure, imidazolyl or benzimidazolyl derivatives. The imidazolyl derivative may be substituted at 2 position from among the group consisting of aroyl, p-chloroaroyl, phenyl hydroxy methine or p-chloro phenyl hydroxy methine or with n-butyl at 2 position and chlorine at 4 and 5 position. In the alternative , when it is a benzimadazolyl derivative, with hydrogen at 6 position, the substituent at 2 position may be selected from among methyl, ethyl, isopropyl, 2-oxoprop-1-yl, n-propyl, methoxy methyl, propen-1-yl, phenyl, p-chlorophenyl, p-toluyl, benzyl, 4-pyridyl, p-methoxy phenyl, 3-pyridyl, o-methoxy phenyl, styryl, 2-cyano methyl, p-hydroxy phenyl, p-amino phenyl, p-toluyl sulfonyl methyl or p-(t-butyl) phenyl group and if hydrogen is at 2 position, the substituent at the 6 position is selected from among nitro, trifluoromethyl or methoxy group.